S. 3187 As Amended; A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes.
On Passage of the Bill
05/24/2012
Senate Roll Call No. 111
112nd Congress, 2nd Session
By 96 yeas to 1 nay (Vote No. 111), Senate passed S. 3187, to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars.